Assembly Biosciences ASMB
NASDAQ ASMB
$23.48 -0.13 (-0.55%)
At close: Sep 29, 2026 · 4:00 PM EDT

Assembly Biosciences (ASMB) Total Current Liabilities (2010 - 2026)

Updated

Assembly Biosciences (ASMB) posted Total Current Liabilities of $23.45 million for Q2 2026, down 50.4% from $47.29 million a year earlier and down 33.0% from the prior quarter.

Analysis

Assembly Biosciences (ASMB) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Assembly Biosciences' Total Current Liabilities came in at $48.78 million, up 2.0% from FY2024.

  • Annual Total Current Liabilities has increased for four consecutive years, with a five-year compound annual growth rate of 14.8% (FY2020 to FY2025).
  • In prior years, Assembly Biosciences' Total Current Liabilities was $47.8 million in FY2024 (+21.9%), $39.23 million in FY2023 (+140.7%), $16.3 million in FY2022 (+1.4%) and $16.07 million in FY2021 (-34.2%).
  • The Q2 2026 figure stands as the lowest quarterly Total Current Liabilities since Q3 2023.
  • On a year-over-year basis, Total Current Liabilities increased in six of the last eight quarters, with growth averaging 61.9%.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q3 2024, with growth of 483.8%; the weakest was Q3 2023, with a decline of 53.9%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $35 million (Q1 2026), $48.78 million (Q4 2025) and $53.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Assembly Biosciences 468.67 Mn -558.96 Mn - 23.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.45 Mn
Mar 31, 2026 35.00 Mn
Dec 31, 2025 48.78 Mn
Sep 30, 2025 53.38 Mn
Jun 30, 2025 47.29 Mn
Mar 31, 2025 46.63 Mn
Dec 31, 2024 47.80 Mn
Sep 30, 2024 41.64 Mn
Jun 30, 2024 41.27 Mn
Mar 31, 2024 38.75 Mn
Dec 31, 2023 39.23 Mn
Sep 30, 2023 7.13 Mn
Jun 30, 2023 8.83 Mn
Mar 31, 2023 9.97 Mn
Dec 31, 2022 16.30 Mn
Sep 30, 2022 15.46 Mn
Jun 30, 2022 14.96 Mn
Mar 31, 2022 10.71 Mn
Dec 31, 2021 16.07 Mn
Sep 30, 2021 14.93 Mn
API Access

Assembly Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ASMB&period=max&api_key=YOUR_API_KEY